Clinical Trials on Tumor, Cerebellar in Japan

Total 380 results

Kissei Pharmaceutical Co., Ltd.

Completed

A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Daiichi Sankyo Co., Ltd.

Recruiting

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Tenosynovial Giant Cell Tumor

Japan
Hokkaido Pancreatobiliary Endoscopic Intervention...
Hokkaido University Hospital

Completed

EUS-FNA for Patients With Antithrombotic Agents

Solid Tumor

Japan
Genmab
BioNTech SE

Recruiting

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Malignant Solid Tumor

Japan
Genmab
BioNTech SE

Active, not recruiting

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Solid Tumor

Japan
AstraZeneca

Completed

A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan

Advanced Solid Tumor

Japan
Novartis Pharmaceuticals

Terminated

Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan

Cancer | Solid Tumor | Advanced Solid Tumor

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

SCD

Japan
Toshihiko Doi
Merck Sharp & Dohme LLC; Oncolys BioPharma Inc

Completed

Special Combination of OBP-301 and Pembrolizumab

Advanced Solid Tumor

Japan
Kyowa Kirin Co., Ltd.
Ono Pharmaceutical Co. Ltd

Completed

Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors

Solid Tumor

Japan
Toray Industries, Inc

Recruiting

A Study of TRK-950 in Patients With Advanced Solid Tumors

Solid Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-7913 Phase I Study (ONO-7913)

Solid Tumor

Japan
Daiichi Sankyo Co., Ltd.

Recruiting

A Study of DS-1471a In Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Eli Lilly and Company

Completed

A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Novartis Pharmaceuticals

Completed

A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

Malignant Solid Tumor

Japan
Kohei Shitara
Ono Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.

Completed

Regorafenib and Nivolumab Simultaneous Combination Therapy (REGONIVO)

Advanced and Metastatic Solid Tumor

Japan
SymBio Pharmaceuticals

Completed

SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
AstraZeneca

Completed

Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies

Advanced Solid Tumor | Advanced Solid Malignancy

Japan
Merck KGaA, Darmstadt, Germany

Completed

A Study of EMD525797 in Solid Tumor Patients in Japan

Solid Tumor

Japan
Takara Bio Inc.

Completed

A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions

Solid Tumor

Japan
Novartis Pharmaceuticals

Completed

A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Novartis Pharmaceuticals

Completed

A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Array Biopharma, now a wholly owned subsidiary...

Completed

A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Noile-Immune Biotech, Inc

Recruiting

Study of NIB101 in Participants With Advanced Solid Tumors

Solid Tumor

Japan
Sanofi

Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors

Solid Tumor

Japan
Chiba University

Unknown

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Pancreatic Tumor | Bile Duct Tumor

Japan
Novartis Pharmaceuticals

Completed

An East Asian Study of LDE225

Medulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor Cancers

Taiwan, Hong Kong, Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of LY2523355 in Patients With Solid Cancer (2523355-001)

Solid Tumors

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Tumors

Japan
zr Pharma & GmbH

Completed

A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

Advanced Solid Tumor

Japan
Eli Lilly and Company
Parexel; Medidata Solutions

Completed

A Study of IMC-A12 in Advanced Solid Tumors

Tumors

Japan
AstraZeneca

Completed

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

Solid Tumor

Japan
Eisai Co., Ltd.

Completed

A Study of MORAb-003 in Patients With Solid Tumor

Neoplasms | Solid Tumor

Japan
Incyte Biosciences Japan GK

Completed

A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors

Advanced Solid Tumors | Metastatic Solid Tumors

Japan
Eli Lilly and Company

Completed

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

Solid Tumors

Japan
Novartis Pharmaceuticals

Completed

Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors

Cancer | Advanced Solid Tumor

Japan
Astellas Pharma Inc

Completed

Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

Solid Tumor

Japan
AbbVie (prior sponsor, Abbott)

Completed

A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors

Solid Tumors

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KRN951 in Patients With Solid Tumors

Solid Tumors

Japan
Daiichi Sankyo Co., Ltd.

Completed

Study of DS-1123a in Advanced Solid Tumours

Advanced Solid Malignant Tumors

Japan
Daiichi Sankyo Co., Ltd.

Terminated

Open Label Study of DS-5573a

Advanced Solid Malignant Tumors

Japan
Astellas Pharma Inc

Completed

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies

Japan
Eisai Inc.

Completed

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Cancer: Solid Tumors

Japan

Clinical Trials on Tumor, Cerebellar in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations